logo

For the Inventor, By the Inventor

Jack W Szostak

Boston, MA, United States of America

Jack W Szostak

Nobel Prize

This inventor holds 16 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: The General Hospital Corporation, Genetics Institute, Inc., The Public Health Research Institute of the City of New York, Inc.. Active years: 1993-2012. Nobel Prize laureate.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jack W Szostak. Retrieved from https://idiyas.com/inventor/jack-w-szostak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 

% Patents Active = 87.5


Average Co-Inventor Count = 2.7

ph-index = 12

Forward Citations = 1,361(Granted Patents)


Company Filing History:

goldMedal13 out of 3,073 
 
The General Hospital Corporation
 patents
silverMedal1 out of 392 
 
Genetics Institute, Inc.
 patents
bronzeMedal1 out of 29 
 
The Public Health Research Institute of the City of New York, Inc.
 patents
4. 1 out of 834,513 
Other
 patents

Years Active: 1993-2012

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 8207093 - Selection of proteins using RNA-protein fusions (2012-06-26),
2. 7270950 - Nucleic acid-protein fusions and methods of making and selecting fusions (2007-09-18),
3. 7138253 - Streptavidin-binding peptides and uses thereof (2006-11-21),
4. 6841359 - Streptavidin-binding peptides and uses thereof (2005-01-11),
5. 6518018 - RNA-antibody fusions and their selection (2003-02-11),
6. 6281344 - Nucleic acid-protein fusion molecules and libraries (2001-08-28),
7. 6261804 - Selection of proteins using RNA-protein fusions (2001-07-17),
8. 6258558 - Method for selection of proteins using RNA-protein fusions (2001-07-10),
9. 6238865 - Simple and efficient method to label and modify 3′-termini of RNA using DNA polymerase and a synthetic template with defined overhang nucleotides (2001-05-29),
10. 6214553 - Libraries of protein encoding RNA-protein fusions (2001-04-10),
11. 6207446 - Selection of proteins using RNA-protein fusions (2001-03-27),
12. 5910408 - Catalytic DNA having ligase activity (1999-06-08),
13. 5688670 - Self-modifying RNA molecules and methods of making (1997-11-18),
14. 5652107 - Diagnostic assays and kits for RNA using RNA binary probes and a (1997-07-29),
15. 5631146 - DNA aptamers and catalysts that bind adenosine or (1997-05-20),

Title: Jack W Szostak: Pioneering Innovator in Molecular Biology

Introduction:

Jack W Szostak, a distinguished inventor based in Boston, MA (US), has made significant contributions to the field of molecular biology through his relentless pursuit of innovation. His work has cemented his position as a trailblazing figure in the scientific community.

Latest Patents:

Among his impressive portfolio of 16 patents, Jack Szostak's latest innovations include "Selection of Proteins using RNA-Protein Fusions" and "Nucleic Acid-Protein Fusions and Methods of Making and Selecting Fusions." These patents showcase his expertise in RNA-protein fusion production methods involving high salt post-translational incubation steps.

Career Highlights:

Having worked at esteemed institutions such as The General Hospital Corporation and Massachusetts General Hospital Corporation, Jack Szostak has demonstrated a remarkable dedication to advancing the frontiers of molecular biology. His groundbreaking research has led to the development of novel techniques and methodologies in the field.

Collaborations:

Throughout his career, Jack Szostak has collaborated with notable peers such as Richard W Roberts and Rihe Liu. These partnerships have facilitated the exchange of ideas, driving innovation and pushing the boundaries of scientific discovery.

Conclusion:

In conclusion, Jack W Szostak's unwavering commitment to innovation, combined with his pioneering spirit in molecular biology, has earned him well-deserved recognition as a visionary inventor. His groundbreaking patents and collaborative efforts underscore his profound impact on the scientific landscape, shaping the future of biotechnological advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…